Glioma

Oncology·MeSH: Glioma

Prevalence

0.1 / 100K

40 drugs in development·24 companies·30 clinical trials

Drug Pipeline by Phase

Approved(5)

Drug	Company
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
modeyso	Jazz Pharmaceuticals plc (JAZZ)
ojemda	XOMA Royalty Corporation (XOMA)
ojemda	Day One Biopharmaceuticals, Inc. (DAWN)
Welireg	Merck & Co., Inc. (MRK)

Phase 3(12)

Drug	Company
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 & AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 and AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons A10 and AS2-1	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
chemotherapeutic agent	Day One Biopharmaceuticals, Inc. (DAWN)
hmpl-306	HUTCHMED (China) Ltd (HMDCF)
onc201	CHIMERIX INC (CMRX)
ONC201	Jazz Pharmaceuticals plc (JAZZ)
ONC206	Jazz Pharmaceuticals plc (JAZZ)
safusidenib	Nuvation Bio Inc. (NUVB)
temozolomide	Black Diamond Therapeutics, Inc. (BDTX)
tovorafenib	Day One Biopharmaceuticals, Inc. (DAWN)

Phase 2(10)

Drug	Company
CLD-101 (NeuroNova™)	Calidi Biotherapeutics Inc. (CLDI)
clr 131	Cellectar Biosciences, Inc. (CLRB)
DNX-2401	Jazz Pharmaceuticals plc (JAZZ)
Entrectinib	Filana Therapeutics Inc. (FLNA)
Entrectinib	Structure Therapeutics Inc. (GPCR)
Etoposide	Structure Therapeutics Inc. (GPCR)
gomekli	SpringWorks Therapeutics, Inc. (SWTX)
ot-101	Oncotelic Therapeutics, Inc. (OTLC)
Paxalisib	Jazz Pharmaceuticals plc (JAZZ)
Pegfilgrastim	Filana Therapeutics Inc. (FLNA)

Phase 1(9)

Drug	Company
AG-120	Valneva SE (VALN)
AG881	Valneva SE (VALN)
AG881	AGIOS PHARMACEUTICALS, INC. (AGIO)
CAN-3110	Candel Therapeutics, Inc. (CADL)
linoserpaturev	Candel Therapeutics, Inc. (CADL)
mb-101	MUSTANG BIO, INC. (MBIO)
mb-108	MUSTANG BIO, INC. (MBIO)
PTC596	PTC THERAPEUTICS, INC. (PTCT)
tovorafenib drug	Day One Biopharmaceuticals, Inc. (DAWN)

Preclinical(1)

Drug	Company
ateganosine	MAIA Biotechnology, Inc. (MAIA)

BLA Filed(1)

Drug	Company
dordaviprone	CHIMERIX INC (CMRX)

Phase 4(2)

Drug	Company
olutasidenib + tmz	RIGEL PHARMACEUTICALS INC (RIGL)
Paxalisib	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 40 drugs in development for Glioma across 24 companies.

There are 30 clinical trials targeting Glioma tracked by BioSniper.

The estimated prevalence of Glioma is approximately 0.1 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.